Autonomix Medical Net Income From Continuing Ops Over Time
| AMIX Stock | 0.40 0 0.50% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Autonomix Medical Performance and Autonomix Medical Correlation. Autonomix | Build AI portfolio with Autonomix Stock |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autonomix Medical. If investors know Autonomix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Autonomix Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Autonomix Medical Common's market price often diverges from its book value, the accounting figure shown on Autonomix's balance sheet. Smart investors calculate Autonomix Medical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Autonomix Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Autonomix Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Autonomix Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Autonomix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare Autonomix Medical Common and related stocks such as Movano Inc, Flora Growth Corp, and Kala Pharmaceuticals Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOVE | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (13 M) | (21.8 M) | (30.3 M) | (29.3 M) | (23.7 M) | (21.4 M) | (22.4 M) |
| KALA | (19.4 M) | (19.4 M) | (19.4 M) | (19.4 M) | (19.4 M) | (16.7 M) | (33.2 M) | (42.2 M) | (66.7 M) | (94.3 M) | (96.2 M) | (142.6 M) | (44.8 M) | (46.4 M) | (38.5 M) | (34.7 M) | (36.4 M) |
| VERO | (21.8 M) | (21.8 M) | (21.8 M) | (21.8 M) | (21.8 M) | (21.8 M) | (21.8 M) | (17.8 M) | (28.7 M) | (42.3 M) | (82.8 M) | (22.1 M) | (43.6 M) | (35.8 M) | (47 M) | (42.3 M) | (44.4 M) |
| OGEN | (7.7 M) | (7.7 M) | (13.1 M) | (16.1 M) | (5.8 M) | (11.7 M) | (8.5 M) | (6.7 M) | (9.9 M) | (15.6 M) | (26.4 M) | (15.7 M) | (14.3 M) | (10.1 M) | (10.6 M) | (9.5 M) | (10 M) |
| DHAI | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (12.1 M) | (2.4 M) | 640.2 K | 640.2 K | 736.2 K | 773 K |
| HSCS | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (2.5 M) | (4.8 M) | (6.4 M) | (6.6 M) | (8.8 M) | (7.9 M) | (8.3 M) |
| BBLG | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (13.9 M) | (21 M) | (7.1 M) | (4.4 M) | (3.4 M) | (1.8 M) | (1.6 M) | (1.5 M) | (6.5 M) | (4.1 M) | (4.7 M) | (5 M) |
| AIM | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (14.4 M) | (19.1 M) | (19.4 M) | (29 M) | (17.3 M) | (15.6 M) | (16.4 M) |
Autonomix Medical Common and related stocks such as Movano Inc, Flora Growth Corp, and Kala Pharmaceuticals Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Autonomix Medical Common | AMIX |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 21 Waterway Avenue, |
| Exchange | NASDAQ Exchange |
null 0.398
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.